HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan D Rohrer Selected Research

Asymptomatic Diseases

1/2022Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
3/2015Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan D Rohrer Research Topics

Disease

56Frontotemporal Dementia (Semantic Dementia)
08/2022 - 03/2010
25Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2022 - 11/2006
14Alzheimer Disease (Alzheimer's Disease)
08/2022 - 08/2010
12Atrophy
01/2022 - 04/2010
10Primary Progressive Aphasia
12/2022 - 01/2010
8Disease Progression
01/2022 - 03/2015
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2017
6Dementia (Dementias)
08/2022 - 01/2016
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 10/2018
5Neuroinflammatory Diseases
10/2021 - 01/2017
5Tauopathies
12/2019 - 09/2012
4Aphasia (Dysphasia)
12/2022 - 06/2010
4Pick Disease of the Brain (Pick's Disease)
01/2021 - 09/2011
4Parkinsonian Disorders (Parkinsonism)
01/2020 - 06/2013
3Sarcoma (Soft Tissue Sarcoma)
09/2011 - 07/2010
2Hepatolenticular Degeneration (Wilson's Disease)
01/2022 - 01/2021
2Gliosis
01/2022 - 01/2020
2Asymptomatic Diseases
01/2022 - 03/2015
2Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia)
03/2012 - 06/2010
1Parkinson Disease (Parkinson's Disease)
01/2022
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022
1Cerebral Cortical Thinning
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Leukoencephalopathies
04/2017
1Pathologic Processes
11/2016
1Blepharospasm
09/2016
1Hypokinesia (Bradykinesia)
09/2016
1Myoclonus (Nocturnal Myoclonus)
09/2016
1Dystonia (Limb Dystonia)
09/2016
1Sialorrhea
09/2016
1Cognitive Dysfunction
01/2016
1Proteostasis Deficiencies
06/2015
1Amnesia (Dissociative Amnesia)
01/2015
1Corticobasal Degeneration
09/2011
1Cytomegalovirus Infections (Inclusion Disease)
09/2011
1Rare Diseases (Rare Disease)
09/2011
1Inclusion Body Myositis
08/2011
1Dysarthria (Spastic Dysarthria)
08/2011
1Osteitis Deformans (Paget's Disease of Bone)
08/2011
1Broca Aphasia (Expressive Aphasia)
08/2010

Drug/Important Bio-Agent (IBA)

39Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2014
26ProgranulinsIBA
12/2022 - 03/2008
13Proteins (Proteins, Gene)FDA Link
11/2021 - 04/2009
11DNA-Binding Proteins (DNA Binding Protein)IBA
12/2019 - 03/2010
7Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2022 - 09/2011
5Amyloid (Amyloid Fibrils)IBA
01/2022 - 11/2013
5UbiquitinIBA
09/2011 - 03/2008
4Levodopa (L Dopa)FDA LinkGeneric
01/2021 - 04/2010
3Glial Fibrillary Acidic ProteinIBA
01/2022 - 01/2020
3GranulinsIBA
01/2022 - 01/2021
3Biological ProductsIBA
01/2022 - 01/2018
3Phosphotransferases (Kinase)IBA
01/2021 - 01/2017
2Protein Isoforms (Isoforms)IBA
01/2022 - 01/2017
2Pharmaceutical PreparationsIBA
01/2022 - 01/2021
2neuronal pentraxinIBA
01/2022 - 01/2020
2Prion ProteinsIBA
10/2017 - 11/2006
2PrionsIBA
11/2016 - 11/2014
2DNA (Deoxyribonucleic Acid)IBA
03/2012 - 09/2011
1CopperIBA
01/2022
1IronIBA
01/2022
1SuspensionsIBA
11/2021
1ChemokinesIBA
10/2021
1LipidsIBA
01/2021
1AntigensIBA
08/2020
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2020
1chitotriosidaseIBA
01/2020
1Apolipoprotein E4IBA
12/2019
1ApolipoproteinsIBA
12/2019
1Apolipoproteins E (ApoE)IBA
12/2019
1Superoxide Dismutase-1IBA
01/2019
1Amyloidogenic ProteinsIBA
01/2019
1SilkFDA Link
01/2019
1HLA-DQA2 antigenIBA
01/2019
1OrexinsIBA
12/2018
1HLA-DRB1 Chains (HLA DRB1)IBA
10/2018
1Untranslated RNA (Noncoding RNA)IBA
10/2018
1DipeptidesIBA
05/2018
1Amyloid beta-PeptidesIBA
01/2018
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
04/2017
1tau Proteins (tau Protein)IBA
01/2017
1Adenosine Triphosphatases (ATPase)IBA
01/2017
1BaclofenFDA LinkGeneric
09/2016
1Antipsychotic Agents (Antipsychotics)IBA
09/2016
1Botulinum Toxins (Botulinum Toxin)IBA
09/2016
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2016
1Levetiracetam (Keppra)FDA LinkGeneric
09/2016
1Cholinesterase Inhibitors (Anticholinesterases)IBA
09/2016
1BenzodiazepinesIBA
09/2016
1Lamotrigine (Lamictal)FDA LinkGeneric
01/2015
1Biological FactorsIBA
04/2013
1Valosin Containing ProteinIBA
08/2011
1Alkaline PhosphataseIBA
08/2011
13' Untranslated Regions (3' UTR)IBA
04/2011
1Complement System Proteins (Complement)IBA
07/2010
1RNA-Binding Protein FUSIBA
07/2010

Therapy/Procedure

5Therapeutics
01/2020 - 04/2010
2Aftercare (After-Treatment)
01/2015 - 05/2006
1Precision Medicine
01/2021
1Language Therapy (Language Training)
04/2020
1Wearable Electronic Devices
01/2020